NSE · MARKSANS
Marksans Pharma Limited
₹333.00
+9.76%
Market Cap
15,090.23 Cr
P/E Ratio
36.12
P/B Ratio
4.94
ROE
13.76%
ROCE
17.54%
Dividend Yield
—
52W High
₹336.60
52W Low
₹156.00
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 |
|---|---|---|
| Revenue | 840.80 Cr | 856.11 Cr |
| Net Profit | 159.41 Cr | 149.03 Cr |
| EPS | 3.47 | 3.27 |
| Operating Profit | 213.58 Cr | 206.31 Cr |
Shareholding pattern
Promoter
43.87%
Public
56.13%
FII
—
DII
—
Recent corporate actions
No corporate actions on record for this stock.
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.